These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9322827)
1. The treatment of severe hypertension with trandolapril, verapamil, and hydrochlorothiazide. Trandolapril/Verapamil Multicenter Study Group. Punzi HA; Novrit BA J Hum Hypertens; 1997 Aug; 11(8):477-81. PubMed ID: 9322827 [TBL] [Abstract][Full Text] [Related]
2. Blood pressure and aortic elastic properties--verapamil SR/trandolapril compared to a metoprolol/hydrochlorothiazide combination therapy. Breithaupt-Grögler K; Gerhardt G; Lehmann G; Notter T; Belz GG Int J Clin Pharmacol Ther; 1998 Aug; 36(8):425-31. PubMed ID: 9726695 [TBL] [Abstract][Full Text] [Related]
3. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
4. Verapamil SR/trandolapril combination therapy for the elderly hypertensive patient. German VeraTran Hypertension Study Group. Holzgreve H; Compagnone D; Zilles P J Hum Hypertens; 1999 Jan; 13(1):61-7. PubMed ID: 9928754 [TBL] [Abstract][Full Text] [Related]
5. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Messerli F; Frishman WH; Elliott WJ Am J Hypertens; 1998 Mar; 11(3 Pt 1):322-7. PubMed ID: 9544873 [TBL] [Abstract][Full Text] [Related]
6. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of combination therapy with trandolapril and verapamil sr in primary hypertension: a 4 x 4 trial design. The Trandolapril Study Group. DeQuattro V; Lee D; Messerli F Clin Exp Hypertens; 1997 Apr; 19(3):373-87. PubMed ID: 9107443 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Sareli P; Radevski IV; Valtchanova ZP; Libhaber E; Candy GP; Den Hond E; Libhaber C; Skudicky D; Wang JG; Staessen JA Arch Intern Med; 2001 Apr; 161(7):965-71. PubMed ID: 11295959 [TBL] [Abstract][Full Text] [Related]
9. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension. Muijsers RB; Curran MP; Perry CM Drugs; 2002; 62(17):2539-67. PubMed ID: 12421112 [TBL] [Abstract][Full Text] [Related]
10. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials. Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388 [TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of the efficacy and safety of trandolapril 2 mg and hydrochlorothiazide 25 mg in patients with mild-to-moderate essential hypertension. Investigator Study Group. Meyer BH; Pauly NC J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S77-80. PubMed ID: 7527107 [TBL] [Abstract][Full Text] [Related]
12. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. McGill JB; Reilly PA Clin Ther; 2001 Jun; 23(6):833-50. PubMed ID: 11440284 [TBL] [Abstract][Full Text] [Related]
13. Controlled multicenter study with quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension. Romero R; Castellote E; Ocón J; Wagner B J Cardiovasc Pharmacol; 1995 Jul; 26(1):114-8. PubMed ID: 7564350 [TBL] [Abstract][Full Text] [Related]
15. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group. DeQuattro V; Lee D Am J Hypertens; 1997 Jul; 10(7 Pt 2):138S-145S. PubMed ID: 9231890 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists. Karlberg BE; Andrup M; Odén A Blood Press; 2000; 9(2-3):140-5. PubMed ID: 10855738 [TBL] [Abstract][Full Text] [Related]
17. A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study. Atalar E; Eskin F; Tugtekin HB; Karabulut A; Kanyilmaz S; Kirbiyik H; Ozyildiz AG Biomed Res Int; 2020; 2020():2123601. PubMed ID: 32964020 [TBL] [Abstract][Full Text] [Related]
18. Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study). Brunner M; Cooper-DeHoff RM; Gong Y; Karnes JH; Langaee TY; Pepine CJ; Johnson JA; Am J Cardiol; 2007 Jun; 99(11):1549-54. PubMed ID: 17531579 [TBL] [Abstract][Full Text] [Related]
19. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers. Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ; Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension. Oparil S; Aurup P; Snavely D; Goldberg A Am J Cardiol; 2001 Mar; 87(6):721-6. PubMed ID: 11249890 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]